Arctic Vision and Santen Ink Deal for ARVN001 Commercialization in China
China-based ophthalmology specialist, Arctic Vision, has entered into a strategic collaboration with Japan’s Santen Pharmaceutical...
Arctic Vision
Eyenovia, Inc. Receives FDA Approval for Mydcombi, a First-of-Its-Kind Ophthalmic Spray
US-based Eyenovia, Inc. (NASDAQ: EYEN) has announced obtaining market approval from the US Food and...
Arctic Vision Partners with Sinopharm Group for Ophthalmic Product Distribution in China
China-based ophthalmology specialist Arctic Vision has entered into a strategic partnership with Sinopharm Group Distribution...
Arctic Vision Enrolls First Patient in Phase III Study for ARVN002
China-based ophthalmology specialist Arctic Vision has announced the enrollment of the first patient in a...
Arctic Vision Administers First Injection of ARVN001 for Uveitis Macular Edema
China-based ophthalmic therapies developer Arctic Vision has announced the first injection of triamcinolone acetonide suprachoroidal...
Arctic Vision Enrolls First Patient in ARVN003 Phase III Trial for Presbyopia
China-based ophthalmic therapies developer Arctic Vision announced the first patient enrollment in a Phase III...